Skip to main content
Tatiana Yakovleva on Muck Rack

Tatiana Yakovleva

As seen in: Color Research & Application, MDPI, The Journal of Immunology

Get in touch with Tatiana

Contact Tatiana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

IJMS | Free Full-Text | Overexpression of RPOTmp Being Targeted to Either Mitochondria or Chloroplasts in Arabidopsis Leads to Overall Transcriptome Changes and Faster Growth

|
By Igor V. Gorbenko, Vladislav Tarasenko, Tatiana Yakovleva, Elena Y. Garnik
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

A model‐based approach to investigating the relationship between glucose‐insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes

|
By Millie Shah, Leonid Stolbov, Tatiana Yakovleva, Weifeng Tang
| Color Research & Application Verified
ORIGINAL ARTICLE Joanna Parkinson PhD Corresponding Author joanna.parkinson@astrazeneca.com orcid.org/0000-0003-4492-5243 Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden Correspondence Joanna Parkinson, PhD, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Open in Who Shared Issue with article?

Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors

|
By Tatiana Yakovleva, Victor Sokolov, Lulu Chu, Weifeng Tang
| Color Research & Application Verified
1 INTRODUCTION Type 2 diabetes mellitus (T2DM) is the most common form of diabetic metabolic disorder (>90% of all cases), characterized by abnormally high plasma glucose concentrations, resulting from resistance to insulin, defects in insulin synthesis and secretion, or both.1 The World Health Organization estimates that diabetes will be the seventh leading cause of death in 2030, driven by cardiovascular and renal sequelae accompanying the disease.2 Treatment of T2DM includes diet, exercise...
Open in Who Shared Issue with article?
See all 8 articles